Actions of the lymph system include regulating the total amount of liquids in the limbs and fighting infections. When lymph nodes in the armpit are damaged or removed, patients can’t appropriately regulate the fluid within their affected arm – which leads to swelling that may range between mild to extensive and quite disfiguring. ‘Statistically, that is a public health problem,’ says Schmitz. ‘It impacts up to one-fifty % of the nearly two million breast-tumor survivors alive in the U.S.announced today that the U.S. Food and Drug Administration has recognized and has filed for review the business’s New Drug Software for pixantrone as treatment for relapsed or refractory intense non-Hodgkin’s lymphoma . A Prescription Drug User Fee Act time will be set up by the FDA concerning the review of the pixantrone NDA by September 4th 2009. ‘The FDA’s acceptance to file our pixantrone NDA represents a significant milestone for CTI and for individuals with relapsed and refractory intense NHL. We anticipate dealing with the FDA and their final decision on our request for priority review,’ observed James Bianco, M.D., Chief Executive Officer of CTI..

Other articles from "clinical laboratory":

Random articles